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 2 
Abstract  24 
Physiological mechanisms associated with interleukin-13 (IL-13), a key cytokine in asthma, 25 
in intracellular Ca2+ signaling in airway smooth muscle cells (ASMCs) remain unclear. The 26 
aim of this study was to assess effects of IL-13 on Ca2+ oscillations in response to 27 
leukotriene D4 (LTD4) in human cultured ASMCs.  28 
         LTD4-induced Ca2+ oscillations in ASMCs pretreated with IL-13 were imaged by 29 
confocal microscopy. mRNA expressions of cysteinyl leukotriene 1 receptors (CysLT1R), 30 
CD38, involved with the ryanodine receptors (RyR) system, and transient receptor potential 31 
canonical (TRPC), involved with store-operated Ca2+ entry (SOCE), were determined by 32 
real-time PCR. In IL-13-pretreated ASMCs, frequency of LTD4-induced Ca2+ oscillations 33 
and number of oscillating cells were significantly increased compared with untreated 34 
ASMCs. Both xestospongin C, a specific inhibitor of inositol 1,4,5-triphosphate receptors 35 
(IP3R), and ryanodine or ruthenium red, inhibitors of RyR, partially blocked LTD4-induced 36 
Ca2+ oscillations. Ca2+ oscillations were almost completely inhibited by 50 μM of 2-37 
aminoethoxydiphenyl borate (2-APB), which dominantly blocks SOCE but not IP3R at this 38 
concentration. Pretreatment with IL-13 increased the mRNA expressions of CysLT1R and 39 
CD38, but not of TRPC1 and TRPC3.  40 
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We conclude that IL-13 enhances frequency of LTD4-induced Ca2+ oscillations in 41 
human ASMCs, which may be cooperatively modulated by IP3R, RyR systems and 42 
possibly by SOCE. 43 
 44 
Key words: airway smooth muscle cells, asthma, Ca2+ oscillation, interleukin-13, 45 
leukotriene D446 
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Abbreviations: 47 
2-APB: 2-aminoethoxydiphenyl borate 48 
ASMCs: airway smooth muscle cells 49 
CICR: calcium induced calcium release  50 
Cys-LTs: cysteinyl leukotrienes 51 
CysLT1R: cysteinyl leukotriene 1 receptor 52 
GPCR: G protein-coupled receptor 53 
IICR: IP3-induced Ca
2+ release  54 
IL: interleukin  55 
IP3R: inositol 1,4,5-triphosphate receptors 56 
RyR: ryanodine receptors  57 
SOCE: store-operated Ca2+ entry  58 
SR: sacroplasmic reticulum 59 
TRPC: transient receptor potential canonical 60 
61 
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1. Introduction  62 
Airway inflammation is a fundamental feature of asthma. Among a number of 63 
inflammatory cytokines and mediators involved in asthma, interleukin (IL)-13, a pleiotropic 64 
Th2 cytokine, plays a pivotal role [1]. In addition to its well-established effects, such as 65 
stimulation of eosinophilic inflammation, induction of goblet cell hyperplasia and airway 66 
fibrosis, previous studies have revealed that IL-13 augments agonist-induced contraction of 67 
the tracheal ring and increases intracellular Ca2+ concentrations ([Ca2+]i) in airway smooth 68 
muscle cells (ASMCs) [2]. Cysteinyl leukotrienes (Cys-LTs; LT-C4, -D4, and -E4) are 69 
metabolites of arachidonic acid and are important agonists for ASMCs by binding the 70 
CysLT1 receptor (CysLT1R), a G protein-coupled receptor (GPCR), and activating 71 
phospholipase C, which leads to the generation of inositol 1,4,5-triphosphate (IP3) followed 72 
by Ca2+ release from sacroplasmic reticulum (SR) [3, 4]. Both IL-13 and Cys-LTs are 73 
produced by mast cells that infiltrate airway smooth muscle layer [5], and a close 74 
relationship between IL-13 and Cys-LTs in asthma pathogenesis has been suggested 75 
recently [6]. 76 
Although intracellular Ca2+ signaling is usually assessed by [Ca2+]i, previous studies 77 
using mouse lung slices [7, 8] have highlighted the importance of Ca2+ oscillations by 78 
                                6  
showing that an increase in oscillation frequency was associated with augmentation of 79 
airway contraction. Ca2+ oscillation is an efficient system for the Ca2+ signaling pathways 80 
by reducing possible deleterious effects due to sustained increases in [Ca2+]i [9]. Currently, 81 
repetitive Ca2+-release systems, such as inositol 1,4,5-triphosphate receptors (IP3R) and/or 82 
ryanodine receptors (RyR) on the SR membrane, are thought to be key systems in agonist-83 
induced Ca2+ oscillations. Furthermore, an interrelationship has been recently proposed 84 
between sustained Ca2+ oscillations and plasma membrane Ca2+ influx, particularly store-85 
operated Ca2+ entry (SOCE) triggered by depletion of Ca2+ in SR [10-12].  86 
Thus far, however, leukotriene D4 (LTD4)-induced Ca2+ oscillations in ASMCs 87 
have not been demonstrated, and the effects of IL-13 on this pathway remain unknown. 88 
In the present study, we aimed to assess the effects of IL-13 on Ca2+ oscillations in 89 
response to LTD4 in human cultured ASMCs, and elucidate the mechanism(s) underlying a 90 
putative augmentation of LTD4-induced Ca2+ oscillations with IL-13 pretreatment.  91 
 92 
2. Methods 93 
2.1.1 Study population and cell preparation 94 
Human ASMCs were obtained from the lungs of 15 patients (10 males; average 68.0 years 95 
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old; lung cancer in 14 patients and granulomatous inflammation in 1) who underwent 96 
surgical resection in accordance with procedures approved by the ethics committee of 97 
Kyoto University. Airway smooth muscle bundles were dissected out and cultured as 98 
described previously [13, 14]. When cells grew to confluence, they were seeded at a density 99 
of 1x104/cm2 into collagen-coated (5 μg/cm2) glass-bottom dishes (Matsunami Glass Ind. 100 
Ltd, Osaka, Japan) for measurements of Ca2+ oscillations or into 6-well culture plates for 101 
measurements of mRNA. In each experiment, cells were cultured in fresh medium 102 
containing IL-13 (10 ng/ml)(Sigma Aldrich, Osaka, Japan) or diluent (PBS with 0.1% 103 
BSA) for 24 hours when they reached subconfluence. The effects of IL-13 on mRNA 104 
expression were also examined at earlier time points, i.e., after 8 hours and 12 hours of 105 
incubation with IL-13. 106 
2.1.2 Measurements of Ca2+ oscillations  107 
Pretreated ASMCs were washed and loaded with a Ca2+-sensitive dye, Fluo-4 AM (5 µM) 108 
(Invitrogen, Molecular probes, CA, USA)[15] for 30 min at 37 °C. After rinsing twice, the 109 
dishes were mounted on a Zeiss LSM510 confocal microscope (Axiovert 200M, Carl Zeiss, 110 
Jena, Germany). In each experiment, 10 min perfusion with modified Krebs solution for 111 
equilibration was followed by perfusion with modified Krebs solution containing LTD4 112 
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(100 nM)(Cayman Chemical, Michigan, US) in the presence or absence of inhibitors: 2-113 
aminoethoxydiphenyl borate (2-APB)(Sigma Aldrich), xestospongin C (Wako, Osaka, 114 
Japan), ruthenium red (Wako), or ryanodine (Calbiochem, Dalmstadt, Germany). The 115 
acquired images were transferred to a BV analyzer (BrainVision, Tokyo, Japan), and the 116 
frequency of Ca2+ oscillations was analyzed. Fluorescence magnitude was expressed as the 117 
ratio of fluorescence relative to the fluorescence level immediately prior to the addition of 118 
an agonist. The temperature of the chamber in which glass-bottom dishes were placed to 119 
measure Ca2+ oscillations was set at 37°C using a temperature controller (Zeiss Model CZI-120 
3, Carl Zeiss). The room temperature was set at 26°C to keep the focus plane constant.  All 121 
measurements were done in duplicate using at least three cell lines each obtained from a 122 
different donor. 123 
2.1.3 Reverse transcription and real-time PCR analysis 124 
Total RNA was extracted from ASMCs using the RNeasy Mini Kit (Qiagen, Osaka, Japan). 125 
cDNA was synthesized and real-time PCR was performed using the ABI Prism 7300 126 
sequence detection system (Applied Biosystems, Tokyo, Japan) with SYBR green (Roche 127 
Diagnostics, Tokyo, Japan). Specific primer sets used are shown in Table 1. The relative 128 
quantity of mRNA expression level of a target molecule was normalized to the mRNA 129 
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expression levels of β-actin and β2 microglobulin in the same sample. 130 
2.1.4 Western Blotting 131 
Protein expression of CysLT1R and CD38 was analyzed by Western blotting and enhanced 132 
chemiluminescence. ASM cells were lysed in a buffer containing 50 mM Tris, 1% 133 
proteinase inhibitor cocktail (Sigma Aldrich), 1% Triton X-100. Protein concentration was 134 
determined measured by the Bio-Rad DC protein assay (Bio-Rad, Osaka, Japan). 10 g of 135 
protein/lane was electrophoresed through 10% SDS-PAGE and transferred to PVDF 136 
membranes (GE Healthcare, Tokyo, Japan). Membranes were blocked with 5% skimmed-137 
milk in Tris-buffered saline and 0.05% Tween 20 and then incubated overnight at 4°C with 138 
the primary antibodies, rabbit anti-CysLT1R antibody (1:200) (Cayman Chemical) or with 139 
mouse anti-CD38 antibody (Santa Cruz Biotechnology, Inc. CA, USA) (1:200) in blocking 140 
solution overnight at 4°C. Secondary anti-rabbit or anti-mouse IgG conjugated with 141 
horseradish peroxidase for use with ECL plus (1:5,000) (GE Healthcare) was incubated for 142 
1 hour at room temperature and visualized using ECL plus Western Blotting Detection 143 
Reagents (GE Healthcare), and quantified by densitometry using ChemiDoc XRS (Bio-144 
Rad).  Data were normalized to the values for GAPDH in the same lane.  145 
2.2 Statistics  146 
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Each result for a single treatment is given as the mean ± SE. Statistical analysis used paired 147 
t tests to compare untreated and treated cells. For the comparison of mRNA expression at 148 
different time points, repeated measures one-way ANOVA with Fisher’s protected least 149 
significant difference correction was employed. p-value < 0.05 indicated statistical 150 
significance. 151 
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3. Results 152 
3.1 LTD4 induces Ca2+ oscillations in ASMCs; pretreatment with IL-13 increases the 153 
number of oscillating cells and oscillation frequency 154 
We first found that 100 nM LTD4 induced an increase in [Ca2+]i followed by Ca
2+ 155 
oscillations in human cultured ASMCs (Fig 1a). In untreated cells, Ca2+ oscillations were 156 
observed in a small percentage of cells (13.0 ± 4.8% of total cells in a visual field) with 157 
relatively low frequencies (0.446 ± 0.140 min-1). However, pretreatment with IL-13 (10 158 
ng/ml) for 24 hours significantly increased the number of oscillating ASMCs to 46.5 ± 159 
5.2% and augmented the frequency of Ca2+ oscillations about 2.6-fold (1.196 ± 0.142 min-1, 160 
p=0.0037; Fig 1b). The amplitude and frequency of Ca2+ oscillations were sustained during 161 
20 min of perfusion with LTD4; the average amplitude level and frequency during the 162 
initial 10 min were maintained at 97.3 ± 6.2% and 91.9 ± 2.6% of these values, 163 
respectively, during the subsequent 10 min.  164 
3.2 IP3R, RyR and SOCE dependence of LTD4-induced Ca
2+ oscillations 165 
To examine the roles of IP3R, RyR and/or SOCE for the Ca
2+ oscillations evoked by LTD4, 166 
IP3R, RyR or SOCE were blocked by inhibitors.  Because the number of oscillating cells 167 
and the number of oscillations in each cell were too few to evaluate quantitatively without 168 
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IL-13 pretreatment, inhibition studies were done with ASMCs pretreated with IL-13. All 169 
inhibitors were added to cell cultures during ongoing LTD4-induced Ca2+ oscillations. 170 
Addition of xestospongin C (10 μM) [16], a specific inhibitor of IP3R, partially inhibited 171 
the amplitude and frequency of LTD4-induced Ca2+ oscillations to 50.6 ± 2.3% (p<0.001) 172 
and 43.6 ± 12.2% (p=0.006) of their initial levels, respectively. Inhibition of RyR by 173 
ruthenium red (200 μM) [17] also partially decreased the amplitude and frequency to 47.7 ± 174 
6.8% (p=0.003) and 47.5 ± 17.6% (p=0.016) of their initial levels, respectively. Ryanodine 175 
(50 μM) was also added to fully close RyR. Ryanodine decreased the amplitude and 176 
frequency to 47.1 ± 1.7% (p=0.001) and 65.0 ± 3.1% (p=0.0006) of their initial levels, 177 
respectively, but also did not abolish the LTD4-induced Ca2+ oscillations (Fig 2a, b). 178 
Meanwhile addition of 2-APB almost completely abrogated the LTD4-induced Ca2+ 179 
oscillations either at 50 μM wherein SOCE is dominantly blocked but not IP3R at this 180 
concentration [11] (Fig 2b) or at higher concentration (200 μM) wherein both IP3R and 181 
SOCE are blocked (Fig 2a, b).  182 
3.3 Effects of IL-13 pretreatment on mRNA expressions of CysLT1R, IP3R type 1, 2, 3, 183 
RyR type 3, CD38, and transient receptor potential canonical (TRPC) in ASMCs 184 
We examined mRNA expressions of molecules that could be involved in IP3R/RyR 185 
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pathways and SOCE, including CysLT1R, IP3R type 1, 2, 3, CD38 and TRPC3 after 8, 12 186 
and 24 hours of incubation with IL-13. CD38 is responsible for the synthesis and 187 
degradation of cyclic ADP ribose, an endogenous ligand for RyR in ASMCs [18]. mRNA 188 
expressions of CysLT1R and CD38, but not TRPC1 and TRPC3, when normalized to the 189 
mRNA expression levels of β-actin, increased significantly within 8 hours of incubation 190 
with IL-13 (p=0.001 for CysLT1R and p=0.007 for CD38) (Fig 3a). There were no 191 
significant changes in mRNA expressions of IP3R type 1, 2, 3, or RyR type 3 (Fig 3a). 192 
Normalization to the mRNA expression levels of β2 micro-globulin did not change the 193 
findings. 194 
3.4 Western blotting  195 
Western blotting analyses were performed to confirm the expressions of CysLT1R and 196 
CD38 protein. Pretreatment with IL-13 for 24 hours significantly increased the density for 197 
CysLT1R or CD38 that was normalized to GAPDH expression (Fig 3b). 198 
199 
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4. Discussion 200 
To the best of our knowledge, we have given the first demonstration that LTD4 201 
induces Ca2+ oscillations in human cultured ASMCs. Moreover, the frequency of Ca2+ 202 
oscillations and the proportion of oscillating cells were significantly enhanced when 203 
ASMCs were pretreated with IL-13. This was partly explained by up-regulation of 204 
CysLT1R and CD38 expression levels after IL-13 pretreatment. Inhibition studies 205 
demonstrated that the LTD4-induced Ca2+ oscillations in IL-13-pretreated ASMCs were 206 
regulated cooperatively by IP3R, RyR and SOCE.  207 
Despite considerable evidence that LTD4 is an important mediator in airway 208 
smooth muscle contraction [4, 19] and proliferation in coupling with IL-13 in asthma [20], 209 
induction of  Ca2+ oscillations by LTD4 and the effects of IL-13 on this pathway remain 210 
unknown. Using real-time confocal microscopy, we confirmed that LTD4 induced Ca2+ 211 
oscillations in human ASMCs, and pretreatment with IL-13 significantly increased the 212 
frequency of LTD4-induced Ca2+ oscillations and the proportion of oscillating ASMCs, 213 
which was accompanied by increases in mRNA expression as well as in protein levels of 214 
CysLT1R and CD38. The increase in CysLT1R expression is consistent with the results of a 215 
previous report that examined proliferation of ASMCs in response to LTD4 after 216 
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pretreatment with IL-13 [20]. This up-regulation of CysLT1R expression by IL-13 217 
pretreatment in our study may have enhanced IP3-induced Ca
2+ release (IICR) / calcium 218 
induced calcium release (CICR) via IP3R as further discussed below, which resulted in an 219 
increased number of oscillating cells and oscillation frequency. Consistent with a previous 220 
study [21], IL-13 also increased CD38 expression that regulates cyclic ADP ribose 221 
metabolism, an endogenous ligand of RyR in ASMCs. Up-regulation of CD38 expression 222 
by IL-13 may have enhanced CICR via RyR.  223 
It is well established that binding of LTD4 to CysLT1R activates phospholipase C 224 
via the Gq protein, which leads to the generation of IP3. After binding IP3, IP3Rs on SR are 225 
activated and open to release Ca2+ from SR, which results in an initial increase in [Ca2+]i. 226 
This priming release of Ca2+ is denoted IICR and this increase of [Ca2+]i
 promotes CICR. It 227 
is currently inconclusive which of the two Ca2+-release systems on the SR membrane, IP3R 228 
or RyR, is responsible for agonist-induced Ca2+ oscillations and governs repetitive Ca2+ 229 
release. The degrees of contributions of IP3R and RyR to CICR may vary among different 230 
cell types [22], species [23] [24] and agonists used [23] [24]. In the present study, both 231 
xestospongin C, a specific inhibitor of IP3R, and ruthenium red or ryanodine, inhibitors of 232 
RyR, suppressed the frequency of Ca2+ oscillations to a similar degree in IL-13-pretreated 233 
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ASMCs. These findings suggest that both IP3R and RyR were involved in Ca
2+ oscillations 234 
in IL-13-pretreated ASMCs.  235 
For sustained Ca2+ oscillations, it is essential to replenish Ca2+ in SR and doing so 236 
requires Ca2+ influx because some Ca2+ is inevitably lost to the extracellular environment. 237 
In ASMCs, SOCE, but not the voltage-gated Ca2+channel, plays an important role in Ca2+ 238 
influx [10]. We also found that SOCE may be involved in LTD4-induced Ca2+ oscillations 239 
in IL-13-pretreated ASMCs because not only 200 μM of 2-APB, which blocks both IP3R 240 
and SOCE, but 50 μM of 2-APB, which dominantly blocks SOCE but not IP3R [11], 241 
inhibited the Ca2+ oscillations almost completely. Consistent with our findings, a recent 242 
study by Gao et al. shows that pretreatment with IL-13 (10 ng/ml) for 24 hours promoted 243 
SOCE in rat ASMCs [25]. However, the molecular mechanisms underlying SOCE were not 244 
clarified in our study. Similar to the study of Gao et al. [25], pretreatment with IL-13 did 245 
not change the mRNA expression of TRPC1. Furthermore the mRNA expression of TRPC3, 246 
which was reported to be up-regulated by tumor necrosis factor-alpha [26], also did not 247 
change. 248 
The oscillation frequency in human cultured ASMCs in this study was slower than 249 
that of ASMCs observed in mouse lung slices [7]. Another study that examined oscillations 250 
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in human cultured ASMCs in response to arachidonic acid also showed a slow frequency 251 
(0.5-1/min) [27]. These reduced responses to LTD4 might be agonist-specific, although the 252 
frequency of histamine-induced Ca2+ oscillations in human cultured ASMCs showed a 253 
range similar to that of LTD4 (data not shown). Using cultured ASMCs might be argued 254 
against because muscarinic receptor M3 is down-regulated in cultured ASMCs. Histamine 255 
H1 receptor and CysLT1R are, however, reported to be retained on cultured ASMCs [28] 256 
and mediate agonist-induced contraction [14]. The system using cultured ASMCs was 257 
advantageous because it can evaluate direct effects of agonists or inhibitors on ASMCs 258 
without the possible confounding influence of other elements, such as epithelium, vascular 259 
endothelium, and inflammatory cells.  260 
In conclusion, we found a substantial effect of IL-13 on LTD4-induced Ca2+ 261 
oscillations in human cultured ASMCs via up-regulation of CysLT1R, which augments the 262 
IP3R system, and CD38, which may be associated with modulating the RyR system. SOCE 263 
may also be involved in LTD4-induced Ca2+ oscillations. These systems, IP3R, RyR, and 264 
possibly SOCE cooperatively modulate agonist-induced Ca2+ oscillations in ASMCs. These 265 
findings may partly explain altered properties of airway smooth muscle in asthma. 266 
267 
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Table 1. Sequences of primer sets for real-time PCR 356 
 357 
CysLT1R  forward primer, 5’-GCACCTATGCTTTGTATGTCAACC-3’  358 
 reverse primer, 5’-ATACCTACACACACAAACCTGGC-3’ 359 
CD38 forward primer, 5’-TGGCCAACTGCGAGTTCAG-3’ 360 
 reverse primer, 5’-GACGAGGATCAGGACCAGGAT-3’ 361 
IP3R type1 forward primer, 5’-TCAATTCGGGAGAGGATGTC-3’ 362 
 reverse primer, 5’-TCGACCAAGTGGATGTGGTA-3’ 363 
IP3R type2 forward primer, 5’-CAACCCTCCCAAGAAGTTCA-3’ 364 
 reverse primer, 5’-GTTTGGCTTGCTTTGCTTTC-3’ 365 
IP3R type3 forward primer, 5’-GCCTTCGACTCTACCACTGC-3’ 366 
 reverse primer, 5’-TTGTCTTCCCCACTCCAAAC-3’ 367 
RyR type3 forward primer, 5’- CGGATGACGTGGTAAGCTG-3’ 368 
 reverse primer, 5’- AGCCCGTCTGTGTTGAAGTTC-3’ 369 
TRPC1 forward primer, 5’- GCCCGGAATTCTCGTGA-3’ 370 
 reverse primer, 5’-AGGTGGGCTTGCGTCGGT-3’ 371 
TRPC3 forward primer, 5’-CAGGCCTAAGGGAGCAGACCATAG-3’ 372 
 reverse primer, 5’-ACTGTGATATTGGGCAGCGTGGTG-3’ 373 
β-actin  forward primer, 5’-AAGAGAGGCATCCTCACCCT-3’ 374 
 reverse primer, 5’-TACATGGCTGGGGTGTTGAA-3’ 375 
β2-MG forward primer, 5’-TGTCTTTCAGCAAGGACTGGTC-3’ 376 
 reverse primer, 5’-CA AACCTCCATGATGCTGC -3’ 377 
 378 
CysLT1R: cysteinyl leukotriene 1 receptor, IP3R: inositol 1,4,5-triphosphate receptors 379 
RyR: ryanodine receptor, β2-MG: β2-microglobulin, TRPC: transient receptor potential canonical 380 
   381 
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 Figure legends 383 
Fig 1. a) Top: Representative images of ASMCs pretreated with IL-13. Raw image of ASMCs 384 
loaded with Ca2+-sensitive fluorescent dye, Fluo-4 AM (left), images in pseudocolor before 385 
(middle) and after (right) LTD4 stimulation. The lowest fluorescence level was assigned a value 386 
of 0 and the brightest a value of 125 in pseudocolor. Bottom: Representative traces of LTD4-387 
induced Ca2+ oscillations in ASMCs pretreated with diluent (black) or with IL-13 (red). After 10 388 
min perfusion with modified Krebs plain solution, 100 nM LTD4 was perfused for 30 min. 389 
Fluorescence magnitude was expressed as ratio of fluorescence relative to the fluorescence 390 
immediately prior to the addition of an agonist. b) Top: Proportion of oscillating ASMCs 391 
responding to LTD4 after pretreatment with either diluent (IL-13 (-)) or IL-13 (10 ng/ml).  392 
* p<0.001 Bottom: Average (boxes) and SE (bars) of the LTD4-induced Ca2+ oscillation 393 
frequency in ASMCs pretreated with either diluent (IL-13 (-)) or IL-13 (n=6 for each group).  394 
† p=0.0037. 395 
 396 
Fig 2. a) Representative traces of 10 μM xestospongin C, 50 μM ryanodine, 200 μM ruthenium 397 
red and 200 μM 2-APB effects on LTD4-induced Ca2+ oscillations of ASMCs pretreated with 398 
IL-13. After 10 min perfusion with modified Krebs plain solution, followed by 10 min with 100 399 
nM LTD4 alone, inhibitors and 100 nM LTD4 were perfused for 20 min. b) Average (boxes) 400 
and SE (bars) of the amplitude and frequency of LTD4-induced Ca2+ oscillations with or 401 
without inhibitors (n=6 for xestospongin C (XC) and 2-APB (50 μM), n=4 for 2-APB (200μM) 402 
and ruthenium red (RR), n=3 for ryanodine (Ry)). Amplitude and frequency of Ca2+ oscillations 403 
during the initial 10 min with an inhibitor and LTD4 (anterior half of gray bar) were normalized 404 
to those during the preceding 10 min of perfusion with LTD4 alone (horizontal white bar). * 405 
p<0.001, †p < 0.05 vs. inhibitor (-). 406 
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 407 
Fig 3. a) Effects of IL-13 (10 ng/ml) on mRNA expressions of cysteinyl leukotriene receptor 1 408 
(CysLT1R), CD38, inositol 1,4,5-triphosphate receptors (IP3R) type 1, 2, and 3, ryanodine 409 
receptor (RyR) type 3, transient receptor potential canonical (TRPC)1, and TRPC3 assessed by 410 
real time PCR (n=4) at 8, 12, and 24 hours. Relative quantity of mRNA expression of a target 411 
molecule was normalized to the mRNA expression of β-actin in the same sample. mRNA level 412 
of a normalized target molecule is given as the ratio to that of a sample pretreated with diluent 413 
only (0 hr). By repeated measures one-way ANOVA, p<0.01 for CysLT1R and CD38; p=0.07 414 
for IP3R3 and RyR3, and p=0.09 for TRPC1; p>0.1 for the others. * p<0.05 vs. 0 hr by post hoc 415 
Fisher’s protected least significant difference correction. b) Effects of IL-13 (10 ng/ml) on 416 
protein levels of CysLT1R, and CD38 assessed by Western blotting (n=3 for each group). 417 
Relative quantity of protein levels of a target molecule was normalized to the protein levels of 418 
GAPDH in the same lane. Protein level of a normalized target molecule is given as the ratio to 419 
that of a sample pretreated with diluent only. * p<0.05 vs. IL-13(-) 420 
 421 
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